Cytokines and Inflammation - Professor Michael Berk

Professor Michael Berk is an NHMRC Senior Principal Research Fellow and Alfred Deakin Chair of Psychiatry at Deakin University and Barwon Health, where he heads the IMPACT Strategic Research Centre. He holds an Honorary position at both Melbourne and Monash University and is a highly cited researcher with over 800 published papers predominantly in mood disorders. His major interests are in the discovery and implementation of novel therapies, and risk factors and prevention of psychiatric disorders. 

Take-Home Points  

• Inflammation has a number of very important effects in neuronal biology. 

• Studies show interesting results for the use of aspirin in schizophrenia and depression, and also in lithium-associated sexual dysfunction in men. 

• ASPREE is a 5-year study of 19,000 healthy individuals to investigate the effect of aspirin on a healthy lifespan and will look at dementia, stroke, heart disease, cancer, diabetes, and depression.

[joyfuljraven]

What an amazing educator, lecturer, and most importantly healer! His passion to find answers to heal are, without a doubt, helping us all! Thank you!

[bannedagain.]

It seems that just about every problem has inflammation with it..and reducing it helps the problem in some way..

[LUV]

What an inspiring and positive. as well as surprising seminar! Thank you for your enthusiasm for finding simple & logical solutions to conditions caused by inflammation.
My son has "treatment resistant" "schizophrenia" & I know he has systemic inflammation & a very unhealthy gut biome due to frequent antibiotics. He is now chronically ill after years on neuroleptic medication & doctors who have no interest in nutritional or other solutions to support his health. Are there any studies going on in the UK he could participate in please? I need to find a solution to get him free - and happy! 🙏💖

[tills]

Very interesting. Have any of these drugs been trialled in psychiatric/ neurological Lyme disease, please?

[louisasmith]

Aspree study sounds remarkable. Five years till the results ... (?)

[alokvkulkarni]

Pioglitazone modulates peroxisome proliferated receptor alpha, and is significantly associated with myocardial infarction. Its use has now been stopped.